Literature DB >> 25349791

Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration in a Turkish population.

Yunus Bulgu1, Gokhan Ozan Cetin2, Vildan Caner3, Ebru Nevin Cetin1, Volkan Yaylali1, Cem Yildirim1.   

Abstract

AIM: To assess the association between age-related macular degeneration (AMD) and three single nucleotide polymorphisms (SNPs) related to the vascular endothelial growth factor (VEGF) gene.
METHODS: The patients who were diagnosed with AMD were included in this prospective study. Three SNPs (rs1413711, rs2146323, and rs3025033) of the VEGF gene were genotyped by real-time polymerase chain reaction in the genomic DNA isolated from peripheral blood samples of the 82 patients and 80 controls.
RESULTS: The genotype frequencies of rs1413711 and rs2146323 were not significantly different between the study group and the control group (P=0.072 and P=0.058). However, there was a significant difference in the genotype frequencies of these SNPs between the wet type AMD and dry type AMD (P=0.005 and P=0.010, respectively). One of the SNPs (rs1413711) was also found to be associated with the severity of AMD (P=0.001) with significant genotype distribution between early, intermediate, and advanced stages of the disease. The ancestral alleles were protective for both SNPs while the polymorphic alleles increased the risk for dry AMD.
CONCLUSION: VEGF SNPs rs1413711 and rs2146323 polymorphisms are significantly associated with AMD subtypes in our population.

Entities:  

Keywords:  age-related macular degeneration; single nucleotide polymorphism; vascular endothelial growth factor

Year:  2014        PMID: 25349791      PMCID: PMC4206879          DOI: 10.3980/j.issn.2222-3959.2014.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

Review 1.  Histopathology of age-related macular degeneration.

Authors:  W R Green
Journal:  Mol Vis       Date:  1999-11-03       Impact factor: 2.367

2.  Pooled-analysis of the associations between three polymorphisms in the VEGF gene and age-related macular degeneration.

Authors:  Yan Lu; Yuhua Shi; Chunyan Xue; Jie Yin; Zhenping Huang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

3.  Homozygosity for the +674C>T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort.

Authors:  Luciana N Almeida; Rachel Melilo-Carolino; Carlos E Veloso; Patrícia A Pereira; Debora M Miranda; Luiz Armando De Marco; Marcio Bittar Nehemy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

4.  VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration.

Authors:  Isao Nakata; Kenji Yamashiro; Hideo Nakanishi; Akitaka Tsujikawa; Atsushi Otani; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2011-07-09       Impact factor: 2.447

5.  VEGF gene polymorphism and response to intravitreal ranibizumab in neovascular age-related macular degeneration.

Authors:  Carlos Eduardo dos Reis Veloso; Luciana Negrão Frota de Almeida; Franco Maria Recchia; David Pelayes; Márcio Bittar Nehemy
Journal:  Ophthalmic Res       Date:  2013-10-22       Impact factor: 2.892

6.  Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6.

Authors:  Jonathan L Haines; Nathalie Schnetz-Boutaud; Silke Schmidt; William K Scott; Anita Agarwal; Eric A Postel; Lana Olson; Shannon J Kenealy; Michael Hauser; John R Gilbert; Margaret A Pericak-Vance
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

7.  The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-11       Impact factor: 5.258

8.  The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

Authors:  Peter James Francis
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

9.  Vascular endothelial growth factor gene variation and the response to photodynamic therapy in age-related macular degeneration.

Authors:  Ilkka Immonen; Sanna Seitsonen; Petri Tommila; Tiia Kangas-Kontio; Sakari Kakko; Eeva-Riitta Savolainen; Markku J Savolainen; M Johanna Liinamaa
Journal:  Ophthalmology       Date:  2009-11-06       Impact factor: 12.079

Review 10.  Mechanism of inflammation in age-related macular degeneration.

Authors:  Francesco Parmeggiani; Mario R Romano; Ciro Costagliola; Francesco Semeraro; Carlo Incorvaia; Sergio D'Angelo; Paolo Perri; Paolo De Palma; Katia De Nadai; Adolfo Sebastiani
Journal:  Mediators Inflamm       Date:  2012-11-07       Impact factor: 4.711

View more
  4 in total

1.  Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis.

Authors:  Martina Barchitta; Andrea Maugeri
Journal:  Dis Markers       Date:  2016-11-23       Impact factor: 3.434

2.  Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.

Authors:  Balasubramaniam Annamalai; Nathaniel Parsons; Marwa Belhaj; Carlene Brandon; Jay Potts; Bärbel Rohrer
Journal:  Transl Vis Sci Technol       Date:  2018-03-09       Impact factor: 3.283

3.  VEGF Gene Polymorphisms are Associated with Risk of Tetralogy of Fallot.

Authors:  Xiang Li; Chao-Liang Liu; Xiao-Xia Li; Qing-Chen Li; Li-Ming Ma; Gao-Li Liu
Journal:  Med Sci Monit       Date:  2015-11-12

4.  VEGFA Haplotype and VEGF-A and VEGF-R2 Protein Associations with Exudative Age-Related Macular Degeneration.

Authors:  Alvita Vilkeviciute; Dzastina Cebatoriene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  Cells       Date:  2022-03-15       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.